Connection
Michael Verneris to Thrombopoietin
This is a "connection" page, showing publications Michael Verneris has written about Thrombopoietin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.187 |
|
|
|
-
Christakopoulos GE, DeFor TE, Hage S, Wagner JE, Linden MA, Brunstein C, Bejanyan N, Verneris MR, Smith AR. Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation. Transplant Cell Ther. 2021 06; 27(6):497.e1-497.e6.
Score: 0.187